Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human FKBPL Protein, N-His

Catalog #:   YHJ77801 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q9UIM3
Protein length: Met1-Gly349
Overview

Catalog No.

YHJ77801

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Met1-Gly349

Predicted molecular weight

40.49 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q9UIM3

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

FK506-binding protein-like, DIR1, FKBPL, NG7, WISp39, WAF-1/CIP1 stabilizing protein 39

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human FKBPL protein
References

The FKBPL-based therapeutic peptide, AD-01, protects the endothelium from hypoxia-induced damage by stabilising hypoxia inducible factor-α and inflammation., PMID:40069829

A long noncoding RNA with enhancer-like function in pig zygotic genome activation., PMID:39749834

Point-of-Care Tests for Preeclampsia: Systematic Review and Meta-Analysis of Diagnostic Test Accuracy Studies., PMID:39663778

ER quality control through reticulophagy and protein secretion., PMID:39603274

Identifying therapeutic targets for kidney stone disease through proteome-wide Mendelian randomization and colocalization analysis., PMID:39585470

Cytosolic FKBPL and ER-resident CKAP4 co-regulates ER-phagy and protein secretion., PMID:39251576

Proteome-wide mendelian randomization identifies therapeutic targets for nephrolithiasis., PMID:39237840

Integrative analysis reveals novel insights into juvenile idiopathic arthritis pathogenesis and shared molecular pathways with associated traits., PMID:39175752

Proteome-wide Mendelian randomization identifies therapeutic targets for ankylosing spondylitis., PMID:38566994

Expression and role of FKBPL in lung adenocarcinoma., PMID:38164287

Improving Women's Health., PMID:37665233

Hsa_circ_0001402 alleviates vascular neointimal hyperplasia through a miR-183-5p-dependent regulation of vascular smooth muscle cell proliferation, migration, and autophagy., PMID:37499939

Vitamins C and D Exhibit Similar Antidepressant Effects to Escitalopram Mediated by NOx and FKBPL in a Stress-Induced Mice Model., PMID:37375593

Quantitative Point of Care Tests for Timely Diagnosis of Early-Onset Preeclampsia with High Sensitivity and Specificity., PMID:37055349

E-Cigarette Aerosol Condensate Leads to Impaired Coronary Endothelial Cell Health and Restricted Angiogenesis., PMID:37047355

FK506-Binding Protein like (FKBPL) Has an Important Role in Heart Failure with Preserved Ejection Fraction Pathogenesis with Potential Diagnostic Utility., PMID:36830764

A placenta-on-a-chip model to determine the regulation of FKBPL and galectin-3 in preeclampsia., PMID:36652019

Loss of Expression of Antiangiogenic Protein FKBPL in Endometrioid Endometrial Carcinoma: Implications for Clinical Practice., PMID:36295491

FK506-binding protein-like and FK506-binding protein 8 regulate dual leucine zipper kinase degradation and neuronal responses to axon injury., PMID:35101451

Non-viral gene delivery utilizing RALA modulates sFlt-1 secretion, important for preeclampsia., PMID:34435509

A novel mutation in FK506 binding protein-like (FKBPL) causes male infertility., PMID:34212559

FKBPL and SIRT-1 Are Downregulated by Diabetes in Pregnancy Impacting on Angiogenesis and Endothelial Function., PMID:34149611

Characterisation of cardiac health in the reduced uterine perfusion pressure model and a 3D cardiac spheroid model, of preeclampsia., PMID:33879252

FKBPL is associated with metabolic parameters and is a novel determinant of cardiovascular disease., PMID:33303872

FK506 binding proteins and inflammation related signalling pathways; basic biology, current status and future prospects for pharmacological intervention., PMID:32622856

Role of A Novel Angiogenesis FKBPL-CD44 Pathway in Preeclampsia Risk Stratification and Mesenchymal Stem Cell Treatment., PMID:32617576

FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer., PMID:31772325

Delivery of RALA/siFKBPL nanoparticles via electrospun bilayer nanofibres: An innovative angiogenic therapy for wound repair., PMID:31676385

FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4., PMID:30975104

An improved reversibly dimerizing mutant of the FK506-binding protein FKBP., PMID:27738551

Low-frequency nonsynonymous variants in FKBPL and ARPC1B genes are associated with breast cancer risk in Chinese women., PMID:27479355

Associations of 6p21.3 Region with Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy., PMID:26861912

RALA-mediated delivery of FKBPL nucleic acid therapeutics., PMID:26419658

Novel endogenous angiogenesis inhibitors and their therapeutic potential., PMID:26364800

WISp39 and Hsp90: actin' together in cell migration., PMID:26257007

Low-frequency coding variants at 6p21.33 and 20q11.21 are associated with lung cancer risk in Chinese populations., PMID:25937444

FKBPL: a marker of good prognosis in breast cancer., PMID:25906750

WISp39 binds phosphorylated Coronin 1B to regulate Arp2/3 localization and Cofilin-dependent motility., PMID:25800056

FKBPL is a critical antiangiogenic regulator of developmental and pathological angiogenesis., PMID:25767277

Biological relevance of Hsp90-binding immunophilins in cancer development and treatment., PMID:25754838

Molecular cochaperones: tumor growth and cancer treatment., PMID:24278769

Identification of RBCK1 as a novel regulator of FKBPL: implications for tumor growth and response to tamoxifen., PMID:23912458

Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathway., PMID:23741069

The anti-migratory effects of FKBPL and its peptide derivative, AD-01: regulation of CD44 and the cytoskeletal pathway., PMID:23457460

Genome-wide association study of age-related macular degeneration identifies associated variants in the TNXB-FKBPL-NOTCH4 region of chromosome 6p21.3., PMID:22694956

The therapeutic and diagnostic potential of FKBPL; a novel anticancer protein., PMID:22265918

The emerging role of FK506-binding proteins as cancer biomarkers: a focus on FKBPL., PMID:21428958

FKBPL and peptide derivatives: novel biological agents that inhibit angiogenesis by a CD44-dependent mechanism., PMID:21364036

Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype., PMID:20479757

Alterations in the steroid hormone receptor co-chaperone FKBPL are associated with male infertility: a case-control study., PMID:20210997

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human FKBPL Protein, N-His [YHJ77801]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only